Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: Distribution, migration, and differentiation

Journal of Hematotherapy and Stem Cell Research

Volumn 12, Issue 3, 2003, Pages 255-270

  Garbuzova Davis, Svitlana ^a   Willing, Alison E ^a   Zigova, Tanja ^a   Saporta, Samuel ^a   Justen, Eleanor B ^c   Lane, Jennifer C ^c   Hudson, Jennifer E ^a   Chen, Ning ^a   Davis, Cyndy D ^b   Sanberg, Paul R ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Saneron CCEL Therapeutics Inc   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA TUBULIN; GLIAL FIBRILLARY ACIDIC PROTEIN; NESTIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; BLOOD CELL; BLOOD TRANSFUSION; BRAIN DEGENERATION; CELL COUNT; CELL DAMAGE; CELL DIFFERENTIATION; CELL MIGRATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; LIFESPAN; MALE; MOTOR NEURON DISEASE; MOUSE; NERVE CELL DEGENERATION; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PARENCHYMA; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD ATROPHY; SPLEEN; STEM CELL; STEM CELL TRANSPLANTATION; UMBILICAL CORD BLOOD;

ALANINE; ANIMALS; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FETAL BLOOD; GLYCINE; HEMATOPOIETIC STEM CELLS; HUMANS; INFUSIONS, INTRAVENOUS; MICE; MICE, TRANSGENIC; MOTOR NEURON DISEASE; SUPEROXIDE DISMUTASE; TRANSPLANTATION, HETEROLOGOUS;

EID: 10744223784     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/152581603322022990     Document Type: Article

References (63)

1. McKay R. (1997). Stem cells in the central nervous system. Science 276:66-71.
2. Gage FH. (2000). Mammalian neural stem cells. Review. Science 287:1433-1438.
3. Bruijn LI. (2002). Amyotrophic lateral sclerosis: from disease mechanisms to therapies. BioTechniques 32:1112-11121.
4. Willing AE, S Garbuzova-Davis, S Saporta, M Milliken, DW Cahill and PR Sanberg. (2001). HNT neurons delay onset of motor deficit in a model of amyotrophic lateral sclerosis. Brain Res Bull 56:525-530.
5. Garbuzova-Davis S, AE Willing, M Milliken, S Saporta, T Zigova, DW Cahill and PR Sanberg. (2002). Positive effect of transplantation of hNT Neurons (Ntera 2/D1 cell-line) in a model of familial amyotrophic lateral sclerosis. Exp Neurol 174:169-180.
6. Garbuzova-Davis S, AE Willing, M Milliken, S Saporta, B Sowerby, DW Cahill and PR Sanberg. (2001). Intraspinal implantation of hNT neurons into SOD1 mice with apparent motor deficit. ALS and Other Motor Neuron Disorders 2:175-180.
7. Rothstein JD. (1996). Excitotoxicity hypothesis. Review. Neurology 47:19-25.
8. Shaw PJ and PG Ince. (1997). Glutamate excitotoxicity and amyotrophic lateral sclerosis. J Neurol 244:3-14.
9. Rosen DR, T Siddique T, D Patterson, DA Figlewicz, P Sapp, A Hentati, D Donaldson, J Goto, JP O'Regan, HX Deng, Z Rahmani, A Krizus, D McKenna-Yasek, A Cayabyab, SM Gaston, R Berger, RE Tanzi, JJ Halperin, B Herzfeld, R Van den Berg, WY Hung, T Birg, G Deng, DW Mulder, C Smyth, NG Laing, E Soriano, MA Perciak-Vance, J Haines, GA Roulou, JS Gusella, HR Horvitz and RH Brown Jr. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial Amyotrophic lateral sclerosis. Nature 362:59-62.
10. Berger MM, N Kopp, C Vital, B Redl, M Aymard and B Lina. (2000). Detection and cellular localization of enterovirus RNA sequences in spinal cord of patients with ALS. Neurology 54:20-25.
11. Niebroj-Dobosz I, A Jamrozik, P Janik, I Hausmanowa-Petrusewicz and H Kwiecinski. (1999). Anti-neural antibodies in serum and cerebrospinal fluid of amyotrophic lateral sclerosis (ALS) patients. Acta Neurol Scand 100:238-243.
12. Alexianu ME. (1995). The role of immune processes in amyotrophic lateral sclerosis pathogenesis. Rom J Neurol Psychiatry 33:215-227.
13. Appel SH, RG Smith, ME Alexianu, JI Engelhardt and E Stefani. (1995). Autoimmunity as an etiological factor in sporadic amyotrophic lateral sclerosis. Review. Adv Neurol 68:47-57.
14. Warita H, Y Itoyama and K Abe. (1999). Selective impairment of fast anterograde axonal transport in the peripheral nerves of asymptomatic transgenic mice with a G93A mutant SOD1 gene. Brain Res 819:120-131.
15. Beaulieu JM, H Jacomy and JP Julien. (2000). Formation of intermediate filament protein aggregates with disparate effects in two transgenic mouse models lacking the neurofilament light subunit. J Neurosci 20:5321-5328.
16. Migheli A, S Cordera, C Bendotti, C Atzori, R Piva and D Schiffer. (1999). S-100 beta protein is upregulated in astrocytes and motor neurons in the spinal cord of patients with amyotrophic lateral sclerosis. Neurosci Lett 261:25-28.
17. Cho KJ, YH Chung, C Shin, DH Shin, YS Kim, ME Gurney, KW Lee and CI Cha. (1999). Reactive astrocytes express p53 in the spinal cord of transgenic mice expressing a human Cu/Zn SOD mutation. NeuroReport 10:3939-3943.
18. Levine JB, J Kong, M Nadler and Z Xu. (1999). Astrocytes interact intimately with degenerating motor neurons in mouse amyotrophic lateral sclerosis (ALS). Glia 28:215-224.
19. Hall ED, J Oostveen and ME Gurney. (1998). Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 23:249-256.
20. Sasaki S and M Iwata. (1996). Ultrastructural study of synapses in the anterior horn neurons of patients with amyotrophic lateral sclerosis. Neurosci Lett 204:53-56.
21. Menzies FM, PG Ince and PJ Shaw. (2002). Mitochondrial involvement in amyotrophic lateral sclerosis. Neurochem Int 40:543-551.
22. Mayany H and PM Lansdorp. (1998). Biology of human umbilical cord blood-derived hematopoietic stem/progenitor cells. Stem Cells 16:153-165.
23. Todaro AM, C Pafumi, G Pernicine, S Munda, MR Pilastro, A Russo, M Farina and A Messing. (2000). Haematopoietic progenitors from umbilical cord blood. Blood Purif 18:144-147.
24. Sanchez-Ramos JR, S Song, SG Kamath, T Zigova, A Willing, F Cardozo-Petaez, T Stedeford and M Chopp. (2001). Expression of neural markers in human umbilical cord blood. Exp Neurol 171:109-115.
25. Sanchez-Ramos JR. (2002). Neural cells derived from adult bone marrow and umbilical cord blood. J Neurosci Res 69:880-893.
26. Bicknese AR, HS Goodwin, CO Quinn and CD Verneake. (2002). Human umbilical cord blood cells can be induced to express markers for neurons and glia. Cell Transplant 11:261-264.
27. Ha Y, JU Choi, DH Yoon, DS Veon, JJ Lee, HO Kim and YE Cho. (2001). Neural phenotype expression of cultured human cord blood cells in vitro. NeuroReport 12:3523-3527.
28. Zigova T, S Song S, AE Willing, JE Hudson, MB Newman, S Saporta, J Sanchez-Ramos and PR Sanberg. (2002). Human umbilical cord blood cells express neural antigens after transplantation into the developing rat brain. Cell Transplant 11:265-274.
29. Chen J, PR Sanberg, Y Li, L Wang, M Lu, AE Willing, J Sanchez-Ramos and M Chopp. (2001). Intravenous administration of human umbilical cord blood reduces behavioral deficit after stroke in rats. Stroke 32:2682-2688.
30. Lu D, PR Sanberg, A Mahmood, Y Li, L Wang, R Sanchez-Ramos and M Chopp. (2002). Intravenous administration of human umbilical cord blood reduces neurological deficit in the rat after traumatic brain injury. Cell Transplant 11:275-285.
31. Kim JJ, S Saporta, AE Willing, ES Fu, LO Colina and PR Sanberg. (2002). Behavioral recovery following intravenous administration of human umbilical cord blood cells in rats with spinal cord injury. Exp Neurol 175:443.
32. Ende N, F Weistein, R Chen and M Ende. (2000). Human umbilical cord blood effect on SOD mice (amyotrophic lateral sclerosis). Life Sci 67:53-59.
33. Chen R and N Ende. (2000). The potential for the use of mononuclear cells from human umbilical cord blood in the treatment of amyotrophic lateral sclerosis in SOD1 mice. J Med 31:21-30.
34. Gurney ME, H Pu, AY Chiu, C Dal Canto, CY Polchow, DD Alexander, J Caliendo, A Hentati, YW Kwon, HX Deng, W Chern, P Zhai, RW Sufit and T Siddique. (1994). Motor neuron degeneration in mice that express a human Cu/Zn superoxide dismutase mutation. Science 264:1772-1775.
35. Mason MRJ, G Campbell, P Caroni, PN Anderson and AR Lieberman. (2000). Overexpression of GAP-43 in thalamic projection neurons of transgenic mice does not enable them to regenerate axons through peripheral nerve grafts. Exp Neurol 165:143-152.
36. Lu M, RN Shen and HE Broxmeyer. (1996). Stem cells from bone marrow, umbilical cord blood and peripheral blood for clinical application: current status and future application. Crit Rev Oncol Hematol 22:61-78.
37. Sirchia G and P Rebulla. (1999). Placental/umbilical cord blood transplantation. Review. Haematologica 84:738-747.
38. Gluckman E, HE Broxmeyer, AD Auerbach, HS Friedman, GW Douglas, A Devergie, H Esperou, D Thierry D, G Socie, P Lehn et al. (1989). Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical cord blood from an HLA-identical sibling. N Engl J Med 321:1174-1178.
39. Gluckman E. (2000). Current status of umbilical cord blood hematopoietic stem cell transplantation. Exp Hematol 28:1197-1205.
40. Rubinstein P, C Carrier, A Scaradavou, J Kurtzberg, J Adamson, AR Migliaccio, RL Berkowitz, M Cabbad, NL Dobrila, PE Taylor, RE Rosenfield and CE Stevens. (1998). Outcomes among 562 recipients of placental blood transplants from unrelated donors. N Engl J Med 339:1565-1577.
41. Wagner JE, JN Barker, TE DeFor, KS Baker, BR Blazar, C Eide, A Goldman, J Kersey, W Krivit, ML MacMillan, PJ Orchard, C Peters, DJ Weisdorf, NKC Ramsay and SM Davies. (2002). Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and non-malignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 100:1611-1618.
42. Ooi J, T Iseki, S Takahashi, A Tomonari, H Nagayama, K Ishii, K Ito, H Sato, T Takahashi, M Shindo, R Sekine, N Ohno, K Uchimaru, F Nagamura, N Shirafuji, A Tojo, K Tani and S Asano. (2002). A clinical comparison of unrelated cord blood transplantation and unrelated bone marrow transplantation for adult patients with acute leukaemia in complete remission. Br J Haematol 118:140-143.
43. Honmou O, S Oka, K Houkin, K Hashi and JD Kocsis. (2002). AC133-positive cells derived from human cord blood remyelinate demyelinated axons in the adult rat spinal cord. Program No. 34.2, 2002 Abstracts Viewer/Itinerary Planner. Washington DC: Society for Neuroscience. CD-ROM.
44. Chiu AY, P Zhai, MC Dal Canto, TM Peters, YW Kwon, SM Prattis and ME Gurney. (1995). Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol Cell Neurosci 6:349-362.
45. Azzouz M, N Leclerc, M Gurney, JM Warter, P Poindron and J Borg. (1997). Progressive motor neuron impairment in an animal model of familial amyotrophic lateral sclerosis. Muscle Nerve 20:45-51.
46. Barneoud P, J Lolivier, DJ Sanger, B Scatton and P Moser. (1997). Quantitative motor assessment in FALS mice: a longitudinal study. NeuroReport 8:2861-2865.
47. Sutherland DR and A Keating. (1992). The CD34 antigen: structure, biology and potential clinical application. J Hematother 1:115-129.
48. Nayar B, GMK Raju and D Deka. (2002). Hematopoietic stem/progenitor cell harvesting from umbilical cord blood. Int J Gynecol Obstetr 79:31-32.
49. Killinburgh D and NH Russel. (1993). Comparative study of CD34 positive cells and subpopulations in human umbilical cord blood and bone-marrow. Bone Marrow Transpl 12:489-494.
50. Hall ED, JOA Oostveen and ME Gurney. (1998). Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 23:249-256.
51. McGeer PL and EG McGeer. (2002). Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve 26:459-470.
52. Elliot JL. (2001). Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis. Brain Res Mol Res 95:172-178.
53. Alexianu ME, M Kozovska and SH Appel. (2001). Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology 57:1282-1289.
54. Hensley K, RA Floyd, B Gordon, S Mou, QN Pye, C Stewart, M West and K Williamson. (2002). Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. J Neurochem 82:365-374.
55. Almer G, C Guegan, P Teismann, A Naini, G Rosoklija, AP Hays, C Chen and S Przedborski. (2001). Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Ann Neurol 49:176-185.
56. Yoshihara T, S Ishigaki, M Yamamoto, Y Liang, J Niwa, H Takeuchi, M Doyu and G Sobue. (2002). Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 80:158-167.
57. Kawamata T, H Akiyama, T Yamada and PL McGeer. (1992). Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol 140:691-707.
58. + cells. Immunology 104:410-417.
59. + cells by human cord blood CD34+ progenitors. Leukemia 12:764-771.
60. + T cells in thymus, cord and adult blood. Immunology 106:190-199.
61. Li Y, SD Douglas and W Ho. (2000). Human stem cells express substance P gene and its receptor. J Hematother Stem Cell Res 9:445-452.
62. Dietl MM, M Sanchez, A Probst and JM Palacios. (1989). Substance P receptors in the human spinal cord: decrease in amyotrophic lateral sclerosis. Brain Res 483:39-49.
63. Barker R. (1991). Substance P and neurodegenerative disorders. A speculative review. Neuropeptides 20:73-78.